Five of the nation’s leading comprehensive cancer centers have joined forces as the UC Cancer Consortium (UCCC) to bring together the expertise of physicians, health professionals, researchers, data scientists and other UC partners on systemwide projects to fight cancer and optimize care.
UCCC initiatives include a joint effort to combine cancer data from all five cancer centers and make it readily available across the UC to revolutionize evidence-based care for UC patients; projects to improve the quality of cancer care; and multi-campus collaborations that address disease- and audience-specific challenges. The UCCC also serves California communities by advocating for cancer-related policies that advance health equity.
The UCCC is led by the directors of the five UC NCI-Designated Comprehensive Cancer Centers. The directors share leadership responsibility by rotating the chair and co-chair roles.
Data and precision oncology
Data-driven precision medicine is increasingly important for delivering the best personalized cancer treatment. The UCCC aims to leverage UC data to foster innovative research and improve cancer patient outcomes. The UCCC is working on enhancing the UC Health Data Warehouse to include de-identified data—such as cancer genomics—to make cancer patient data accessible to UC researchers and scientists.
Improving quality of care
The UCCC brings together providers and health professionals through the UCCC Quality Council to share best practices and collaborate on projects to make evidence-based improvements in care for all UC cancer patients. Current projects include a collaboration with UC Population Health on the UC Way Oncology Medical Home Initiative.
UCCC Molecular Tumor Board
Cancer is not one disease but many diseases, driven by case-specific factors including patient and tumor genomics. The UCCC Molecular Tumor Board provides UC clinicians, scientists and researchers a forum to discuss the best options for individual patients based on the genomic alterations present in their cancer.
Systemwide consortia and collaborations
Teams focused on tumor types, patient populations, and other interest areas collaborate to leverage expertise from throughout the UC system and advance clinical care and research.
UCCC Molecular Tumor Board Virtual Meeting
March 12, 2024 at 8am PT (*New date!)
Register for the Zoom meeting here.
Subscribe to our newsletter
Receive updates from across the UCCC and its groups throughout the year.